Delivery Order SPE2DB20D1100-SPE2DB24FZ08L
- Not listed
- This federal contract award, valued at $7,209.34, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Focalin XR 5 mg capsules, a pharmaceutical product, to support military and veteran healthcare programs. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $8,215.16 and is for the delivery of Focalin XR capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc.,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $4,955.61, is for the delivery of Focalin XR 5 mg capsules (100 count) to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,656.43 firm fixed-price delivery order is for the supply of Focalin XR capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,611.63 for the supply of Focalin XR 15 mg capsules. The contract was awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, and does not have a set-aside designation. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $6,845.06 firm fixed-price delivery order is for the supply of 4,560,824,177 units of Focalin XR 10 mg capsules. The award has an ultimate completion date of May 3, 2023. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,163.15, is a delivery order for 100 units of Focalin XR 15 mg capsules. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,440.58 delivery order is for Focalin XR 15 mg capsules and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award, valued at $2,151.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract is a delivery order for the supply of 100 units of Focalin XR 15 mg capsules, a brand-name medication. This award is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc., which is valued at up to $999,999,999.00 and runs through...
- This federal contract award, valued at $10,168.91, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Focalin XR Capsules 10mg, a prescription medication, with a final completion date of November 8, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FZ08LDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company that is a subsidiary of Cencora, Inc. The contract has a delivery order value of $7,897.43 and covers the delivery of Focalin XR 10 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This IDC, which runs through November 2026, enables the DLA to efficiently procure essential medications and medical commodities. The contract award did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 12/4/23 |